Vir Biotechnology is now a two-engine company, with major pharma partnerships and a fully enrolled hepatitis delta phase 3 ...

Researchers analyzed 44 Bundibugyo virus genomes and modeled how approved and experimental Ebola antibodies might bind the ...

Lund University. For most of his career as a researcher, Lars Björck has sought to understand how bacteria manage to evade ...

How this list was built Scope. Every biotech initial public offering with a first trading day between 1 January and 24 ...

AstraZeneca will buy newly issued convertible preferred stock valued at $18.36 per common share, nearly 19% above Monday’s ...

Treatment options for patients with relapsed/refractory follicular lymphoma have expanded rapidly. CD19-directed CAR T-cell therapies are approved in the third-line setting and beyond, and CD20 x CD3 ...

Researchers at Washington University School of Medicine in St. Louis have developed a potential antibody-based approach to ...

There is no treatment available today to stop the death of brain cells in neurodegenerative diseases known as tauopathies, including Alzheimer's disease, in which twisted clumps of a protein called ...

An NHS GP has explained how nasal and injected flu vaccines protect children, and how age and certain health conditions ...

Xilio Therapeutics Inc. (Nasdaq: XLO) has appointed Yariv J. Houvras, M.D., Ph.D., as chief medical officer, adding an oncology drug... Read More ...